Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc...

FDA Recall #D-0024-2026 — Class III — October 9, 2025

Recall #D-0024-2026 Date: October 9, 2025 Classification: Class III Status: Ongoing

Product Description

Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date

Recalling Firm

STAQ Pharma, Inc. — Denver, CO

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Distribution

Nationwide in the U.S.

Code Information

Lot #: 25156673A, Expiry: 02FEB2026.

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated